Type 2 Diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetic women 40 to 60 years old with overweight With forward shoulder, hyperkiphosis, hyperlordosis abnormalities
Exclusion criteria
Exclusion criteria: Insulin treatment Complications of diabetes (neuropathy, nephropathy, retinopathy) Hormone therapy Smoking, drugs and alcohol, Participating in exercise activities during the last 6 months Any pain and swelling in the measured positions History of cardiovascular and mental illness History of fractures, surgery or joint diseases,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hyperkyphosis. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Flexible Ruler.;Hyperlordosis. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Flexible Ruler.;Shoulder forward. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Double Square device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated Hemoglobin. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Blood test with Biorexfars kit.;HDL Cholesterol. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Blood test with BioSystems kit.;LDL Cholesterol. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Blood test with BioSystems kit.;Triglycerides. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Blood test with BioSystems kit.;Cholesterol. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Blood test with BioSystems kit.;Waist Circumference. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Standard tape meter.;Hip Circumference. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Standard tape meter.;Fasting Blood Glucose. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Blood test with BioSystems kit.;Blood Pressure. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: brachial digital blood pressure monitor.;Insulin Hormone. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Blood test with Siemens kit made in America.;Body Mass Index. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Mark Tanita Body Composition Test Devic | — |
Countries
Iran (Islamic Republic of)
Contacts
Payame Noor University of Tehran (South)